Cancer Interception, research supporting
the earliest diagnosis of pancreatic cancer even before the cancer may have fully formed, is the focus of one of the Dream Teams and one of the Research Teams.
«The identification and initial validation of a highly accurate 5 - gene pancreatic cancer biomarker panel that can discriminate late and early stages of pancreatic cancer from normal pancreas and benign pancreatic lesions could facilitate
early diagnosis of pancreatic cancer,» said co-senior author Roya Khosravi - Far, PhD, Associate Professor of Pathology at BIDMC.
Pancreatic Cancer Action is a UK charity whose aim is to save lives by focusing on improving
early diagnosis of pancreatic cancer.
We have also developed e-learning modules for pharmacists and support staff to help support
the early diagnosis of pancreatic cancer.
United Kingdom About Blog Pancreatic Cancer Action focus on
early diagnosis of pancreatic cancer to give patients the best chance of survival.
Not exact matches
There has been a lack
of reliable markers,
early indicators and risk factors associated with
pancreatic cancer, but this new way
of differentiating between healthy and malignant tissue offers hope for
earlier diagnosis and treatment.»
In a study
of 51 patients, researchers used a state -
of - the art microfluidic device to capture circulating pancreas epithelial cells in 33 percent
of patients with
early pancreatic lesions and no clinical
diagnosis of cancer.
Detection /
Diagnosis:
Pancreatic cancer is very difficult to detect or to diagnose at
early stages
of disease.